Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
It is important to acknowledge the limitations of this study
In addition to the trial results released on April 27, a clinical trial published in the New England Journal of Medicine last year showed that patients who were obese or overweight and had other health conditions such as high blood pressure, high cholesterol, or cardiovascular disease lost 20% of their body weight in 16 months while taking the maximum dose of 15mg
When to Speak with Your GP About GLP-1 and GIP It is important to have an open conversation with your GP before starting any supplement regimen, particularly if you are considering natural products to support metabolic health or blood glucose control
Now in Phase 3 trials (TRIUMPH program), retatrutide continues to demonstrate metabolic benefits
Importantly, these studies rarely measured GLP-1 levels as a mechanism, and the strains tested varied widely
This means more people can access GLP-1 therapy without the barrier of self-injection
